Search results
Results from the WOW.Com Content Network
This is a complete list of estrogens and formulations that are approved by the FDA Tooltip Food and Drug Administration and available in the United States. Estrogens are used as hormonal contraceptives , in hormone replacement therapy , and in the treatment of gynecological disorders .
Mirvetuximab soravtansine, sold under the brand name Elahere, is a medication used as a treatment for epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. [ 2 ] [ 5 ] Mirvetuximab soravtansine is a folate receptor alpha directed antibody and microtubule inhibitor conjugate.
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
Ohio was the only state to consider a statewide abortion rights question in 2023, joining a growing number of states where voters are choosing to protect abortion access since the U.S. Supreme ...
“The Great State of Canada is stunned as the Finance Minister resigns, or was fired, from her position by Governor Justin Trudeau,” Trump posted on Truth Social Monday night.
Developed by Gregory Pincus at G. D. Searle & Company, it was first approved on June 10, 1957, by the U.S. Food and Drug Administration for treatment of menstrual disorders. [1] The FDA approved an additional indication for use as a contraceptive on June 23, 1960, though it only became legally prescribable nationwide and regardless of the woman ...
This foldable storage shelf is on sale for under $60: 'It is like a magic act' AOL. Shop the best New Year's Amazon deals for big savings on Apple, Ninja, Keurig and more. See all deals.
Erdafitinib received an accelerated approval. [7] Further clinical trials are required to confirm erdafitinib's clinical benefit and the sponsor is conducting or plans to conduct these studies. [7] Erdafitinib was also granted breakthrough therapy designation. [7] The FDA granted the approval of Balversa to Janssen Pharmaceutical.